Department of Traditional Chinese Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Hebei University of Chinese Medicine, Shijiazhuang, China.
Eur J Cancer Care (Engl). 2022 Nov;31(6):e13620. doi: 10.1111/ecc.13620. Epub 2022 May 25.
This meta-analysis aims to compare the effects of early palliative care on patients with incurable cancer with those of standard oncologic care or on-demand palliative care.
Pubmed, Embase, Web of Science, Cochrane Library, ClinicalTrials.gov and World Health Organization International Clinical Trials Registry Platform (ICTRP) were searched for relevant randomised controlled trials. We also screened reference lists of included studies for additional qualified studies. We used Cochrane Collaboration Risk of Bias Tool to evaluate quality of included studies. DerSimonian and Laird's random effects meta-analysis was used to synthesise the effects.
Sixteen in 1376 studies were included. The pooled data suggested that patients receiving early palliative care had better quality of life (SMD = 0.737, 95% CI: 0.240-1.234), fewer symptoms (SMD = 0.304, 95% CI: 0.097-0.510), better mood (SMD = -0.443, 95% CI: -0.605 to -0.282), better survival (hazard ratio [HR] of death: HR = 1.521, 95% CI: 1.521-1.923; 1-year overall survival probability: HR = 1.238, 95% CI: 1.031-1.486) and higher probability of dying at home (HR = 1.153, 95% CI: 1.027-1.295) than patients in the control group. And there is no difference between resource use.
Early palliative care improves lives of patients with incurable cancer, but the evidence level is low because of high heterogeneity of quality of life and small numbers of included studies for other results.
本荟萃分析旨在比较对不可治愈癌症患者进行早期姑息治疗与标准肿瘤学治疗或按需姑息治疗的效果。
检索 Pubmed、Embase、Web of Science、Cochrane 图书馆、ClinicalTrials.gov 和世界卫生组织国际临床试验注册平台(ICTRP),以查找相关的随机对照试验。我们还筛选了纳入研究的参考文献列表,以寻找其他合格的研究。我们使用 Cochrane 协作风险偏倚工具评估纳入研究的质量。采用 DerSimonian 和 Laird 的随机效应荟萃分析来综合评估效果。
在 1376 项研究中有 16 项符合纳入标准。汇总数据表明,接受早期姑息治疗的患者生活质量更好(SMD=0.737,95%CI:0.240-1.234),症状更少(SMD=0.304,95%CI:0.097-0.510),情绪更好(SMD=-0.443,95%CI:-0.605 至-0.282),生存率更高(死亡风险比[HR]:HR=1.521,95%CI:1.521-1.923;1 年总生存率概率:HR=1.238,95%CI:1.031-1.486),在家中死亡的可能性更高(HR=1.153,95%CI:1.027-1.295),而对照组患者则没有。且资源利用方面无差异。
早期姑息治疗可改善不可治愈癌症患者的生活,但由于生活质量和其他结果的纳入研究数量较少,存在高度异质性,证据水平较低。